EUVIMEDEUVIMED entdecken
Crossref

Mapping antiretroviral toxicity: eight years of pharmacovigilance signals from a tertiary HIV clinic in Gauteng, South Africa

GR Gudala, N Padayachee, RV Vagiri

SA Pharmaceutical Journal · 01.10.2026 · 93 (5) · 52-58

DOI: 10.36303/sapj.4616 ↗

Kurz gefasst

Fachartikel in der Zeitschrift SA Pharmaceutical Journal, erschienen am 01.10.2026. Verfasst von GR Gudala und 2 weiteren Autor:innen. Die Arbeit nennt 27 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Adverse drug reactions (ADRs) remain a major challenge in the long-term management of HIV/AIDS, particularly in high-burden settings such as South Africa, where antiretroviral therapy (ART) is widely used. Although ART has significantly reduced HIV-related morbidity and mortality, its use is often complicated by toxicities that affect adherence, require regimen changes, and increase healthcare costs. This study aimed to determine the frequency, patterns, and determinants of reported ADRs among adult HIV-positive patients receiving ART at a tertiary hospital in Gauteng Province.

Methods

A retrospective medical records review was conducted using routinely collected clinical data from 2015 to 2022. Data were extracted from the TherapyEdge (TE) electronic system, including demographic, clinical, and treatment variables. A total of 1 310 patients with at least one documented ADR were included. Descriptive statistics summarised ADR patterns, while Pearson’s Chi-square test assessed associations between variables and ADR occurrence.

Results

A total of 1 606 ADRs were identified across nine ART regimens. Renal complications were most frequent (47.8%), followed by gastrointestinal disturbances (22.3%) and hepatic events (9.8%). The tenofovir, emtricitabine, and efavirenz (TEE) regimen accounted for the highest proportion of ADRs (44.1%), with renal dysfunction and anaemia predominating. A significant association was found between ART regimen type and ADR occurrence (p < 0.001), whereas gender, age, and treatment duration were not statistically significant.

Conclusion

These findings highlight the substantial burden of ADRs, particularly with tenofovir-based regimens. Strengthened pharmacovigilance, routine monitoring, and patient-centred regimen selection are essential to improve treatment safety and adherence in resource-limited settings.

Zitieren

APA

Gudala, G., Padayachee, N., & Vagiri, R. (2026). Mapping antiretroviral toxicity: eight years of pharmacovigilance signals from a tertiary HIV clinic in Gauteng, South Africa. SA Pharmaceutical Journal, 93(5), 52-58. https://doi.org/10.36303/sapj.4616

Vancouver

Gudala G, Padayachee N, Vagiri R. Mapping antiretroviral toxicity: eight years of pharmacovigilance signals from a tertiary HIV clinic in Gauteng, South Africa. SA Pharmaceutical Journal. 2026;93(5):52-58. doi:10.36303/sapj.4616

BibTeX
@article{Gudala2026,
  author = {Gudala, GR and Padayachee, N and Vagiri, RV},
  title = {Mapping antiretroviral toxicity: eight years of pharmacovigilance signals from a tertiary HIV clinic in Gauteng, South Africa},
  journal = {SA Pharmaceutical Journal},
  year = {2026},
  volume = {93},
  number = {5},
  pages = {52--58},
  doi = {10.36303/sapj.4616}
}
Kostenlos starten →